Diabetes Self-Management Blog

On April 30, Disetronic Medical Systems, Inc. (a division of Roche) announced a recall of certain Accu-Chek Spirit insulin pumps due to a manufacturing problem: These pumps may be at risk of having their "up" and/or "down" buttons fail with repeated use. Pumps with serial numbers ranging from SN02119552 to SN10006093, which were shipped in the United States, are affected by this recall.

If a pump’s “up” or “down” buttons are defective, it may stop functioning intermittently or completely, in which case pump users may not be able to change any programmed settings on the pump. If the buttons are not working properly, the user will not receive a confirmation signal (a vibration or sound), and the display on the pump will not change when he uses the buttons.

If this failure occurs, users should disconnect the pump and switch to an alternate method of insulin delivery (a backup pump or injections). Then they should call the Accu-Chek Spirit hotline to request a replacement pump, which should arrive in 1–2 business days. The hotline number is (800) 778-5095, and it is available 24 hours a day, 7 days a week.

To learn more about this situation, visit the U.S Food and Drug Administration’s (FDA) page or Disetronic’s page about the recall. You can also call the hotline number above with any questions.


  1. Are there any insulin pumps available that are directly coupled with a continously functioning meter?

    Posted by Carl D. Taulbee |
  2. Dear Mr. Taulbee:

    The Guardian REAL-Time Continuous Glucose Monitoring System is integrated with either the MiniMed Paradigm 522 or the 722 insulin pump in the MiniMed Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System. This system is available from Medtronic.

    Diane Fennell
    Web Editor

    Posted by Diane Fennell |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.

Insulin & Other Injected Drugs
New Weekly Type 2 Diabetes Drug Approved (09/26/14)
Dispelling the Myths of Insulin Therapy (08/01/14)
Insulin for Type 2 (07/14/14)
FDA Approves Inhalable Insulin (07/03/14)

Diabetes News
New Metformin Combination Medicine Approved for Type 2 Diabetes (10/30/14)
FDA Approves Remote Glucose-Monitoring Technology (10/24/14)
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)



Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.